Alerts will be sent to your verified email
Verify EmailBETA
Beta Drugs
|
Syncom Formulations
|
Bliss GVS Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
21.73 % | 8.81 % | 7.87 % |
5yr average Equity Multiplier
|
1.75 | 1.5 | 1.33 |
5yr Average Asset Turnover Ratio
|
1.04 | 0.79 | 0.63 |
5yr Avg Net Profit Margin
|
11.97 % | 7.78 % | 9.44 % |
Price to Book
|
0.0 | 5.91 | 1.5 |
P/E
|
43.07 | 40.88 | 18.68 |
5yr Avg Cash Conversion Cycle
|
15.7 Days | 84.02 Days | 169.17 Days |
Inventory Days
|
43.83 Days | 27.61 Days | 51.37 Days |
Days Receivable
|
87.61 Days | 123.89 Days | 187.07 Days |
Days Payable
|
113.94 Days | 93.18 Days | 75.42 Days |
5yr Average Interest Coverage Ratio
|
13.71 | 39.83 | 15.0 |
5yr Avg ROCE
|
27.85 % | 12.74 % | 14.67 % |
5yr Avg Operating Profit Margin
|
21.58 % | 9.47 % | 17.43 % |
5 yr average Debt to Equity
|
0.23 | 0.2 | 0.13 |
5yr CAGR Net Profit
|
31.07 % | 19.56 % | -4.95 % |
5yr Average Return on Assets
|
12.53 % | 5.89 % | 5.91 % |
Shareholdings
|
|||
Promoter Holding
|
66.73 % | 50.57 % | 35.29 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.02 % | 4.45 % | 2.15 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Beta Drugs
|
Syncom Formulations
|
Bliss GVS Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|